Prellis Biologics Joins the IndieBio SOSV Accelerator Batch 5

Prellis Biologics is a proud member of Batch 5 at IndieBio, the world’s first Synthetic Biology accelerator. IndieBio is devoted to funding and building startups dedicated toward solving humanity’s most pressing problems with life itself.

On Thursday, September 14th, the Batch 5 companies will be debuting at IndieBio's Demo Day at the Herbst Theater in San Francisco. 

Livestream the event here.